MEA Fecal Occult Blood Tests Market - Industry Trends and Forecast to 2030

Description

List of Tables

Middle East & Africa fecal occult blood testing market is projected to register a substantial CAGR of 4.4 % in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation

Middle East & Africa Fecal Occult Blood Tests Market, By Test Type (Lateral Flow Immuno-Fob Test Kits, Immuno-FOB Agglutination Test Kits, Immuno-FOB ELISA Test Kits, Guaiac FOB Stool Test, Flushable Reagent Pad or Tissue, and Others), By Application (Colorectal Cancer Screening, Concern for Gastrointestinal Bleeding, Polyps, Diverticulosis, Ulcers, Haemorrhoids, Colitis, Anemia, and Others), By End User (Diagnostic Laboratories, Hospitals, Speciality Clinics, and Others), By Distribution Channel (Direct Sales, Retail Sales, E-Commerce, and Others), Country(South Africa, Saudi Arabia, UAE, Egypt, Israel and the rest of the Middle East and Africa.), Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Middle East & Africa fecal occult blood testing market are:

Rising cases of colorectal cancer globally

Development of direct-to-consumer laboratory testing

Increasing inclination towards point-of-care diagnostics

Easy availability of fecal occult immunological test devices in online stores

Market Players:

Some of the key market players for the Middle East & Africa fecal occult blood testing market are listed below:

Quidel Corporation

Siemens Healthcare GmbH

Biohit Oyj

Accubiotech Co.Ltd.

Accuquik Test Kits

Aidian

Alfa Scientific Designs, Inc.

Apacor Limited

Others

1 INTRODUCTION 74

1.1 OBJECTIVES OF THE STUDY 74
1.2 MARKET DEFINITION 74
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET 74
1.4 CURRENCY AND PRICING 76
1.5 LIMITATIONS 76
1.6 MARKETS COVERED 76

2 MARKET SEGMENTATION 80

2.1 MARKETS COVERED 80
2.2 GEOGRAPHICAL SCOPE 81
2.3 YEARS CONSIDERED FOR THE STUDY 82
2.4 DBMR TRIPOD DATA VALIDATION MODEL 83
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 86
2.6 MULTIVARIATE MODELLING 87
2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE 87
2.8 MARKET APPLICATION COVERAGE GRID 88
2.9 DBMR MARKET POSITION GRID 89
2.10 VENDOR SHARE ANALYSIS 90
2.11 SECONDARY SOURCES 91
2.12 ASSUMPTIONS 91

3 EXECUTIVE SUMMARY 92

4 PREMIUM INSIGHTS 94

4.1 PESTEL ANALYSIS 95
4.2 PORTER'S 5 FORCES 96

5 INDUSTRY INSIGHTS 97

6 REGULATORY FRAMEWORK 99

6.1 REGULATORY SCENARIO BY U.S. FDA 99
6.2 REGULATORY SCENARIO IN U.S. 99
6.3 REGULATORY SCENARIO IN EUROPE 100
6.4 REGULATORY SCENARIO IN CANADA 100
6.5 REGULATORY SCENARIO IN AUSTRALIA 100

7 MARKET OVERVIEW 101

7.1 DRIVERS 103
- 7.1.1 RISING CASES OF COLORECTAL CANCER MIDDLE EAST & AFRICALY 103
- 7.1.2 DEVELOPMENT OF DIRECT-TO-CONSUMER LABORATORY TESTING 103
- 7.1.3 EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES 104
- 7.1.4 INCREASING INCLINATION TOWARDS POINT-OF-CARE DIAGNOSTICS 104
7.2 RESTRAINTS 104
- 7.2.1 CHANGE IN CONSUMER PREFERENCE TOWARDS COST-EFFECTIVE ALTERNATIVES 104
- 7.2.2 LOW AWARENESS ABOUT FECAL OCCULT BLOOD TESTS IN UNDEVELOPED COUNTRIES 105
7.3 OPPORTUNITIES 105
- 7.3.1 INCREASE IN SCREENING PROCEDURES 105
- 7.3.2 RISING TECHNICAL ADVANCEMENTS 106
- 7.3.3 STRATEGIC INITIATIVES 106
7.4 CHALLENGES 107
- 7.4.1 LACK OF SKILLED PROFESSIONALS 107
- 7.4.2 LOW EFFICIENCY 107

8 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE 108

8.1 OVERVIEW 109
8.2 LATERAL FLOW IMMUNO-FOB TEST KITS 112
8.3 IMMUNO-FOB AGGLUTINATION TEST KITS 112
8.4 IMMUNO-FOB ELISA TEST KITS 113
8.5 GUAIAC FOB STOOL TEST 114
- 8.5.1 KITS 115
  - 8.5.1.1 GUAIAC SLIDES 115
    - 8.5.1.1.1 25 PACKAGE 115
    - 8.5.1.1.2 20 PACKAGE 115
    - 8.5.1.1.3 OTHERS 115
  - 8.5.1.2 ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER 116
    - 8.5.1.2.1 SENSITIVITY IS 50NG/ML 116
    - 8.5.1.2.1.1 25 PACKAGE 116
    - 8.5.1.2.1.2 20 PACKAGE 116
    - 8.5.1.2.1.3 OTHERS 117
    - 8.5.1.2.2 SENSITIVITY IS 75NG/ML 117
    - 8.5.1.2.2.1 25 PACKAGE 117
    - 8.5.1.2.2.2 20 PACKAGE 117
    - 8.5.1.2.2.3 OTHERS 117
    - 8.5.1.2.3 OTHERS 117
  - 8.5.1.3 OTHERS 118
- 8.5.2 REAGENTS 118
  - 8.5.2.1 HYDROGEN PEROXIDE 118
  - 8.5.2.2 OTHERS 118
8.6 FLUSHABLE REAGENT PAD OR TISSUE 118
8.7 OTHERS 119

9 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION 120

9.1 OVERVIEW 121
9.2 COLORECTAL CANCER SCREENING 124
- 9.2.1 LATERAL FLOW IMMUNO-FOB TEST KITS 125
- 9.2.2 IMMUNO-FOB AGGLUTINATION TEST KITS 125
- 9.2.3 IMMUNO-FOB ELISA TEST KITS 125
- 9.2.4 GUAIAC FOB STOOL TEST 125
- 9.2.5 FLUSHABLE REAGENT PAD OR TISSUE 125
- 9.2.6 OTHERS 125
9.3 CONCERN FOR GASTROINTESTINAL BLEEDING 125
- 9.3.1 LATERAL FLOW IMMUNO-FOB TEST KITS 126
- 9.3.2 IMMUNO-FOB AGGLUTINATION TEST KITS 126
- 9.3.3 IMMUNO-FOB ELISA TEST KITS 126
- 9.3.4 GUAIAC FOB STOOL TEST 127
- 9.3.5 FLUSHABLE REAGENT PAD OR TISSUE 127
- 9.3.6 OTHERS 127
9.4 POLYPS 127
- 9.4.1 LATERAL FLOW IMMUNO-FOB TEST KITS 128
- 9.4.2 IMMUNO-FOB AGGLUTINATION TEST KITS 128
- 9.4.3 IMMUNO-FOB ELISA TEST KITS 128
- 9.4.4 GUAIAC FOB STOOL TEST 128
- 9.4.5 FLUSHABLE REAGENT PAD OR TISSUE 128
- 9.4.6 OTHERS 128
9.5 DIVERTICULOSIS 129
- 9.5.1 LATERAL FLOW IMMUNO-FOB TEST KITS 130
- 9.5.2 IMMUNO-FOB AGGLUTINATION TEST KITS 130
- 9.5.3 IMMUNO-FOB ELISA TEST KITS 130
- 9.5.4 GUAIAC FOB STOOL TEST 130
- 9.5.5 FLUSHABLE REAGENT PAD OR TISSUE 130
- 9.5.6 OTHERS 130
9.6 ULCERS 130
- 9.6.1 LATERAL FLOW IMMUNO-FOB TEST KITS 131
- 9.6.2 IMMUNO-FOB AGGLUTINATION TEST KITS 131
- 9.6.3 IMMUNO-FOB ELISA TEST KITS 131
- 9.6.4 GUAIAC FOB STOOL TEST 132
- 9.6.5 FLUSHABLE REAGENT PAD OR TISSUE 132
- 9.6.6 OTHERS 132
9.7 HAEMORRHOIDS 132
- 9.7.1 LATERAL FLOW IMMUNO-FOB TEST KITS 133
- 9.7.2 IMMUNO-FOB AGGLUTINATION TEST KITS 133
- 9.7.3 IMMUNO-FOB ELISA TEST KITS 133
- 9.7.4 GUAIAC FOB STOOL TEST 133
- 9.7.5 FLUSHABLE REAGENT PAD OR TISSUE 133
- 9.7.6 OTHERS 133
9.8 COLITIS 134
- 9.8.1 LATERAL FLOW IMMUNO-FOB TEST KITS 135
- 9.8.2 IMMUNO-FOB AGGLUTINATION TEST KITS 135
- 9.8.3 IMMUNO-FOB ELISA TEST KITS 135
- 9.8.4 GUAIAC FOB STOOL TEST 135
- 9.8.5 FLUSHABLE REAGENT PAD OR TISSUE 135
- 9.8.6 OTHERS 135
9.9 ANEMIA 135
- 9.9.1 LATERAL FLOW IMMUNO-FOB TEST KITS 136
- 9.9.2 IMMUNO-FOB AGGLUTINATION TEST KITS 136
- 9.9.3 IMMUNO-FOB ELISA TEST KITS 136
- 9.9.4 GUAIAC FOB STOOL TEST 137
- 9.9.5 FLUSHABLE REAGENT PAD OR TISSUE 137
- 9.9.6 OTHERS 137
9.10 OTHERS 137

10 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER 138

10.1 OVERVIEW 139
10.2 DIAGNOSTIC LABORATORIES 142
10.3 HOSPITALS 142
10.4 SPECIALITY CLINICS 143
10.5 OTHERS 144

11 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL 145

11.1 OVERVIEW 146
11.2 DIRECT TENDER 149
11.3 RETAIL SALE 149
11.4 E-COMMERCE 150
11.5 OTHERS 151

12 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY REGION 152

12.1 MIDDLE EAST AND AFRICA 153
- 12.1.1 SOUTH AFRICA 168
- 12.1.2 SAUDI ARABIA 178
- 12.1.3 U.A.E. 188
- 12.1.4 EGYPT 198
- 12.1.5 ISRAEL 208
- 12.1.6 REST OF MIDDLE EAST AND AFRICA 218

13 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY LANDSCAPE 219

13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 219

14 SWOT ANALYSIS 220

15 COMPANY PROFILE 221

15.1 QUIDEL CORPORATION 221
- 15.1.1 COMPANY SNAPSHOT 221
- 15.1.2 REVENUE ANALYSIS 221
- 15.1.3 COMPANY SHARE ANALYSIS 222
- 15.1.4 PRODUCT PORTFOLIO 222
- 15.1.5 RECENT DEVELOPMENT 222
15.2 WONDFO. 223
- 15.2.1 COMPANY SNAPSHOT 223
- 15.2.2 COMPANY SHARE ANALYSIS 223
- 15.2.3 PRODUCT PORTFOLIO 224
- 15.2.4 RECENT DEVELOPMENT 224
15.3 SIEMENS HEALTHCARE GMBH 225
- 15.3.1 COMPANY SNAPSHOT 225
- 15.3.2 REVENUE ANALYSIS 225
- 15.3.3 COMPANY SHARE ANALYSIS 226
- 15.3.4 RODUCT PORTFOLIO 226
- 15.3.5 RECENT DEVELOPMENT 226
15.4 EIKEN CHEMICAL CO., LTD. 227
- 15.4.1 COMPANY SNAPSHOT 227
- 15.4.2 REVENUE ANALYSIS 227
- 15.4.3 COMPANY SHARE ANALYSIS 228
- 15.4.4 PRODUCT PORTFOLIO 228
- 15.4.5 RECENT DEVELOPMENT 228
15.5 BIOHIT OYJ 229
- 15.5.1 COMPANY SNAPSHOT 229
- 15.5.2 REVENUE ANALYSIS 229
- 15.5.3 COMPANY SHARE ANALYSIS 230
- 15.5.4 PRODUCT PORTFOLIO 230
- 15.5.5 RECENT DEVELOPMENT 230
15.6 ACCUBIOTECH CO LTD 231
- 15.6.1 COMPANY SNAPSHOT 231
- 15.6.2 PRODUCT PORTFOLIO 231
- 15.6.3 RECENT DEVELOPMENT 231
15.7 ACCUQUIK TEST KITS 232
- 15.7.1 COMPANY SNAPSHOT 232
- 15.7.2 PRODUCT PORTFOLIO 232
- 15.7.3 RECENT DEVELOPMENT 232
15.8 AIDIAN 233
- 15.8.1 COMPANY PROFILE 233
- 15.8.2 PRODUCT PORTFOLIO 233
- 15.8.3 RECENT DEVELOPMENT 233
15.9 ALFA SCIENTIFIC DESIGNS, INC. 234
- 15.9.1 COMPANY SNAPSHOT 234
- 15.9.2 PRODUCT PORTFOLIO 234
- 15.9.3 RECENT DEVELOPMENT 234
15.10 APACOR LIMITED 235
- 15.10.1 COMPANY SNAPSHOT 235
- 15.10.2 PRODUCT PORTFOLIO 235
- 15.10.3 RECENT DEVELOPMENT 235
15.11 BIOPANDA REAGENTS LTD 236
- 15.11.1 COMPANY SNAPSHOT 236
- 15.11.2 PRODUCT PORTFOLIO 236
- 15.11.3 RECENT DEVELOPMENT 236
15.12 BODITECH MED INC. 237
- 15.12.1 COMPANY SNAPSHOT 237
- 15.12.2 PRODUCT PORTFOLIO 237
- 15.12.3 RECENT DEVELOPMENT 237
15.13 CENOGENICS CORPORATION 238
- 15.13.1 COMPANY SNAPSHOT 238
- 15.13.2 PRODUCT PORTFOLIO 238
- 15.13.3 RECENT DEVELOPMENT 238
15.14 CERTEST BIOTEC. 239
- 15.14.1 COMPANY SNAPSHOT 239
- 15.14.2 PRODUCT PORTFOLIO 239
- 15.14.3 RECENT DEVELOPMENT 239
15.15 CTK BIOTECH, INC. 240
- 15.15.1 COMPANY SNAPSHOT 240
- 15.15.2 PRODUCT PORTFOLIO 240
- 15.15.3 RECENT DEVELOPMENT 240
15.16 EDP BIOTECH 241
- 15.16.1 COMPANY SNAPSHOT 241
- 15.16.2 PRODUCT PORTFOLIO 241
- 15.16.3 1.16.3 RECENT DEVELOPMENT 241
15.17 EPITOPE DIAGNOSTICS, INC. 242
- 15.17.1 COMPANY SNAPSHOT 242
- 15.17.2 PRODUCT PORTFOLIO 242
- 15.17.3 RECENT DEVELOPMENT 242
15.18 EUROLYSER DIAGNOSTICA GMBH 243
- 15.18.1 COMPANY SNAPSHOT 243
- 15.18.2 PRODUCT PORTFOLIO 243
- 15.18.3 RECENT DEVELOPMENT 243
15.19 FIRSTEP 244
- 15.19.1 COMPANY SNAPSHOT 244
- 15.19.2 PRODUCT PORTFOLIO 244
- 15.19.3 RECENT DEVELOPMENT 244
15.20 HANGZHOU CLONGENE BIOTECH CO., LTD 245
- 15.20.1 COMPANY SNAPSHOT 245
- 15.20.2 PRODUCT PORTFOLIO 245
- 15.20.3 RECENT DEVELOPMENT 245

15.21 HUMASIS.COM 246
- 15.21.1 COMPANY SNAPSHOT 246
- 15.21.2 PRODUCT PORTFOLIO 246
- 15.21.3 RECENT DEVELOPMENT 246
15.22 JANT PHARMACAL CORPORATION 247
- 15.22.1 COMPANY SNAPSHOT 247
- 15.22.2 PRODUCT PORTFOLIO 247
- 15.22.3 RECENT DEVELOPMENT 247
15.23 PRIMA LAB SA 248
- 15.23.1 COMPANY SNAPSHOT 248
- 15.23.2 PRODUCT PORTFOLIO 248
- 15.23.3 RECENT DEVELOPMENT 248
15.24 ULTI MED PRODUCTS (DEUTSCHLAND) GMBH 249
- 15.24.1 COMPANY SNAPSHOT 249
- 15.24.2 PRODUCT PORTFOLIO 249
- 15.24.3 RECENT DEVELOPMENT 249

16 QUESTIONNAIRE 250

17 RELATED REPORTS 253

LIST OF TABLES

TABLE 1 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 63
TABLE 2 MIDDLE EAST & AFRICA LATERAL FLOW IMMUNO-FOB TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 64
TABLE 3 MIDDLE EAST & AFRICA IMMUNO-FOB AGGLUTINATION TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 4 MIDDLE EAST & AFRICA IMMUNO-FOB ELISA TEST KITS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 65
TABLE 5 MIDDLE EAST & AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 66
TABLE 6 MIDDLE EAST & AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 66
TABLE 7 MIDDLE EAST & AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 67
TABLE 8 MIDDLE EAST & AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 67
TABLE 9 MIDDLE EAST & AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 68
TABLE 10 MIDDLE EAST & AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 68
TABLE 11 MIDDLE EAST & AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 69
TABLE 12 MIDDLE EAST & AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 70
TABLE 13 MIDDLE EAST & AFRICA FLUSHABLE REAGENT PAD OR TISSUE IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 71
TABLE 14 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT MARKET, BY REGION, 2021-2030 (USD MILLION) 71
TABLE 15 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 75
TABLE 16 MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 17 MIDDLE EAST & AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 76
TABLE 18 MIDDLE EAST & AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 78
TABLE 19 MIDDLE EAST & AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 78
TABLE 20 MIDDLE EAST & AFRICA POYLPS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 79
TABLE 21 MIDDLE EAST & AFRICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 80
TABLE 22 MIDDLE EAST & AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 81
TABLE 23 MIDDLE EAST & AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 81
TABLE 24 MIDDLE EAST & AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 25 MIDDLE EAST & AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 83
TABLE 26 MIDDLE EAST & AFRICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 27 MIDDLE EAST & AFRICA HEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 85
TABLE 28 MIDDLE EAST & AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 86
TABLE 29 MIDDLE EAST & AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 86
TABLE 30 MIDDLE EAST & AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 31 MIDDLE EAST & AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 88
TABLE 32 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 89
TABLE 33 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 93
TABLE 34 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 94
TABLE 35 MIDDLE EAST & AFRICA HOSPITALS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 36 MIDDLE EAST & AFRICA SPECIALITY CLINICS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 95
TABLE 37 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 96
TABLE 38 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 100
TABLE 39 MIDDLE EAST & AFRICA DIRECT TENDER IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 40 MIDDLE EAST & AFRICA RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 41 MIDDLE EAST & AFRICA RETAIL SALE IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 42 MIDDLE EAST & AFRICA OTHERS IN FECAL OCCULT BLOOD TESTS MARKET, BY REGION, 2021-2030 (USD MILLION) 103
TABLE 43 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, 2021-2030 (USD MILLION) 109
TABLE 44 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 109
TABLE 45 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 109
TABLE 46 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 110
TABLE 47 MIDDLE EAST AND AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 110
TABLE 48 MIDDLE EAST AND AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 110
TABLE 49 MIDDLE EAST AND AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 110
TABLE 50 MIDDLE EAST AND AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 111
TABLE 51 MIDDLE EAST AND AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 111
TABLE 52 MIDDLE EAST AND AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 111
TABLE 53 MIDDLE EAST AND AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 111
TABLE 54 MIDDLE EAST AND AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 112
TABLE 55 MIDDLE EAST AND AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 112
TABLE 56 MIDDLE EAST AND AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 112
TABLE 57 MIDDLE EAST AND AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 112
TABLE 58 MIDDLE EAST AND AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 112
TABLE 59 MIDDLE EAST AND AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 113
TABLE 60 MIDDLE EAST AND AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 113
TABLE 61 MIDDLE EAST AND AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 113
TABLE 62 MIDDLE EAST AND AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 113
TABLE 63 MIDDLE EAST AND AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 113
TABLE 64 MIDDLE EAST AND AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 114
TABLE 65 MIDDLE EAST AND AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 114
TABLE 66 MIDDLE EAST AND AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 114
TABLE 67 MIDDLE EAST AND AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 114
TABLE 68 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 69 MIDDLE EAST AND AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 115
TABLE 70 MIDDLE EAST AND AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 71 MIDDLE EAST AND AFRICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 116
TABLE 72 MIDDLE EAST AND AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 117
TABLE 73 MIDDLE EAST AND AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 117
TABLE 74 MIDDLE EAST AND AFRICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 118
TABLE 75 MIDDLE EAST AND AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 118
TABLE 76 MIDDLE EAST AND AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 119
TABLE 77 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 119
TABLE 78 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 119
TABLE 79 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 120
TABLE 80 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 120
TABLE 81 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 120
TABLE 82 SOUTH AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
TABLE 83 SOUTH AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 121
TABLE 84 SOUTH AFRICA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 121
TABLE 85 SOUTH AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 121
TABLE 86 SOUTH AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 121
TABLE 87 SOUTH AFRICA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 122
TABLE 88 SOUTH AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
TABLE 89 SOUTH AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 122
TABLE 90 SOUTH AFRICA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 122
TABLE 91 SOUTH AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 122
TABLE 92 SOUTH AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 123
TABLE 93 SOUTH AFRICA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 123
TABLE 94 SOUTH AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 123
TABLE 95 SOUTH AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 123
TABLE 96 SOUTH AFRICA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 123
TABLE 97 SOUTH AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 124
TABLE 98 SOUTH AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 124
TABLE 99 SOUTH AFRICA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 124
TABLE 100 SOUTH AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 124
TABLE 101 SOUTH AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 124
TABLE 102 SOUTH AFRICA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 125
TABLE 103 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
TABLE 104 SOUTH AFRICA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 125
TABLE 105 SOUTH AFRICA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
TABLE 106 SOUTH AFRICA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 126
TABLE 107 SOUTH AFRICA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
TABLE 108 SOUTH AFRICA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 127
TABLE 109 SOUTH AFRICA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
TABLE 110 SOUTH AFRICA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
TABLE 111 SOUTH AFRICA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 129
TABLE 112 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 129
TABLE 113 SOUTH AFRICA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 129
TABLE 114 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 130
TABLE 115 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 130
TABLE 116 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 130
TABLE 117 SAUDI ARABIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
TABLE 118 SAUDI ARABIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 131
TABLE 119 SAUDI ARABIA GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 131
TABLE 120 SAUDI ARABIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
TABLE 121 SAUDI ARABIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 131
TABLE 122 SAUDI ARABIA KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 132
TABLE 123 SAUDI ARABIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 124 SAUDI ARABIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 132
TABLE 125 SAUDI ARABIA GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 132
TABLE 126 SAUDI ARABIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
TABLE 127 SAUDI ARABIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 133
TABLE 128 SAUDI ARABIA ALPHA GUAIACONIC ACID (GUAIAC) IMPREGNATED PAPER IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 133
TABLE 129 SAUDI ARABIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 133
TABLE 130 SAUDI ARABIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 133
TABLE 131 SAUDI ARABIA SENSITIVITY IS 50NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 133
TABLE 132 SAUDI ARABIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 134
TABLE 133 SAUDI ARABIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 134
TABLE 134 SAUDI ARABIA SENSITIVITY IS 75NG/ML IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 134
TABLE 135 SAUDI ARABIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 134
TABLE 136 SAUDI ARABIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 134
TABLE 137 SAUDI ARABIA REAGENTS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 135
TABLE 138 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
TABLE 139 SAUDI ARABIA COLORECTAL CANCER SCREENING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
TABLE 140 SAUDI ARABIA CONCERN FOR GASTROINTESTINAL BLEEDING IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
TABLE 141 SAUDI ARABIA POLYPS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 136
TABLE 142 SAUDI ARABIA DIVERTICULOSIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
TABLE 143 SAUDI ARABIA ULCERS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 137
TABLE 144 SAUDI ARABIA HAEMORRHOIDS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
TABLE 145 SAUDI ARABIA COLITIS IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 138
TABLE 146 SAUDI ARABIA ANEMIA IN FECAL OCCULT BLOOD TESTS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
TABLE 147 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY END USER, 2021-2030 (USD MILLION) 139
TABLE 148 SAUDI ARABIA FECAL OCCULT BLOOD TESTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139
TABLE 149 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 140
TABLE 150 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 140
TABLE 151 U.A.E. FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 140
TABLE 152 U.A.E. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
TABLE 153 U.A.E. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 141
TABLE 154 U.A.E. GUAIAC FOB STOOL TEST IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 141
TABLE 155 U.A.E. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
TABLE 156 U.A.E. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 141
TABLE 157 U.A.E. KITS IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 142
TABLE 158 U.A.E. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
TABLE 159 U.A.E. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (UNIT) 142
TABLE 160 U.A.E. GUAIAC SLIDES IN FECAL OCCULT BLOOD TESTS MARKET, BY TEST TYPE, 2021-2030 (ASP) 142

LIST OF FIGURES

FIGURE 1 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTSMARKET: SEGMENTATION 31
FIGURE 2 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: DATA TRIANGULATION 34
FIGURE 3 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: DROC ANALYSIS 35
FIGURE 4 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 36
FIGURE 5 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY RESEARCH ANALYSIS 36
FIGURE 6 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: INTERVIEW DEMOGRAPHICS 37
FIGURE 7 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: MARKET APPLICATION COVERAGE GRID 39
FIGURE 8 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTSMARKET: DBMR MARKET POSITION GRID 40
FIGURE 9 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: VENDOR SHARE ANALYSIS 41
FIGURE 10 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: SEGMENTATION 44
FIGURE 11 RISING CASES OF COLORECTAL CANCER MIDDLE EAST & AFRICALY AND EASY AVAILABILITY OF FECAL OCCULT IMMUNOLOGICAL TEST DEVICES IN ONLINE STORES ARE EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET FROM 2023 TO 2030 45
FIGURE 12 THE LATERAL FLOW IMMUNO-FOB, TEST KITS SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET IN 2023 & 2030 45
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET 53
FIGURE 14 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2022 60
FIGURE 15 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 61
FIGURE 16 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, CAGR (2023-2030) 61
FIGURE 17 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY TEST TYPE, LIFELINE CURVE 62
FIGURE 18 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2022 72
FIGURE 19 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 73
FIGURE 20 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, CAGR (2023-2030) 73
FIGURE 21 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY APPLICATION, LIFELINE CURVE 74
FIGURE 22 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2022 90
FIGURE 23 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, 2023-2030 (USD MILLION) 91
FIGURE 24 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY END USER, CAGR (2023-2030) 91
FIGURE 25 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY END USER, LIFELINE CURVE 92
FIGURE 26 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2022 97
FIGURE 27 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 98
FIGURE 28 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 98
FIGURE 29 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE 99
FIGURE 30 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: SNAPSHOT (2022) 105
FIGURE 31 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022) 106
FIGURE 32 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2023 & 2030) 106
FIGURE 33 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: BY COUNTRY (2022 & 2030) 107
FIGURE 34 MIDDLE EAST AND AFRICA FECAL OCCULT BLOOD TESTS MARKET: TEST TYPE (2023-2030) 107
FIGURE 35 MIDDLE EAST & AFRICA FECAL OCCULT BLOOD TESTS MARKET: COMPANY SHARE 2022 (%) 170